Correctol

Quick links to important sections

Correctol

Method of action: Laxative

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Correctol

What is Correctol?

Correctol is a brand-name medication commonly used for the short-term relief of occasional constipation. It belongs to a class of drugs known as stimulant laxatives. The active ingredient in the most common formulation of Correctol is bisacodyl, though the brand has historically offered products containing other ingredients, such as stool softeners like docusate sodium.

Mechanism of Action

Correctol works by directly interacting with the muscles of the intestinal wall. As a stimulant laxative, the active ingredient increases the rhythmic contractions (peristalsis) of the colon. This movement helps to transport stool through the bowel more quickly. Additionally, it can influence the accumulation of water and electrolytes in the intestines, which softens the stool and further facilitates a bowel movement.

Primary Use

The medication is primarily intended for individuals experiencing infrequent bowel movements or difficulty passing stool. It is designed to provide predictable relief, typically producing results within a few hours when taken orally. Because of its mechanism of action, it is categorized as a temporary solution rather than a long-term treatment for digestive issues.

Regulatory References

  1. NIH StatPearls: Bisacodyl

What side effects are possible with Correctol?

Possible Side Effects

Correctol, which may contain docusate sodium (a stool softener) or bisacodyl (a stimulant laxative), can cause various side effects. Commonly reported effects related to either active ingredient include abdominal cramping, nausea, diarrhea, and stomach discomfort.

Specific formulations containing docusate sodium, especially liquids or syrups, may cause throat irritation or a bitter taste. Long-term or excessive use of any laxative can lead to more serious issues, such as dehydration and electrolyte imbalance, particularly low potassium levels (hypokalemia), which may affect heart function.


Serious Adverse Reactions and Warnings

Seek immediate medical attention if any signs of a severe allergic reaction occur, such as a rash, hives, swelling of the face, tongue, or throat, or difficulty breathing. Stop use and consult a healthcare professional if you experience rectal bleeding, fail to have a bowel movement after using the product, or have a sudden change in bowel habits that lasts longer than two weeks. These may be signs of a serious medical condition.

Correctol should not be used if you have abdominal pain, nausea, or vomiting unless directed by a doctor, as these symptoms can indicate a serious condition like intestinal obstruction. Prolonged or chronic use of stimulant laxatives like bisacodyl is not recommended as it may lead to laxative dependence, where the bowels may become reliant on medication for function. Do not use for more than one week without medical advice.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation details the specific signs and actions required in cases of Correctol (Bisacodyl) overdose or chronic misuse. The risk profile is primarily defined by the resulting physiological disturbances.

Documented Overdose Manifestations

Exposure Scenario Key Manifestations (As Documented)
Acute High Dose Watery stools (diarrhoea), severe abdominal cramps, and clinically significant loss of fluid and electrolytes (including potassium).
Chronic Overdose/Abuse Hypokalaemia (low potassium), chronic diarrhoea, abdominal pain, and severe outcomes such as metabolic alkalosis, renal tubular damage, and renal calculi.

Regulator-Mandated Emergency Actions

Action Area Official Regulatory Statement
Immediate Help Get medical help or contact a Poison Control Center right away.
Supportive Management Procedures may include gastric lavage or inducing vomiting to limit absorption. Treatment requires replacement of fluids and correction of electrolyte imbalance.
Population Note The required replacement of fluids and correction of electrolyte imbalance is cited as especially important in the elderly and the young.

No specific antidote is explicitly documented in the official prescribing information for Bisacodyl overdose. The necessary response centers on addressing the severe fluid and electrolyte imbalance to prevent serious complications.

Therapeutic Uses of Correctol

What Correctol Treats: Main Uses and Benefits

Correctol, which contains the active ingredient bisacodyl, is applied across domains where additional symptomatic support is needed, such as in situations involving occasional constipation and irregularity. The product is relevant in contexts involving certain distressing symptoms, such as difficulty passing stool.

The medication is commonly used across conditions presenting with acute episodes and may assist with providing supportive relief when symptoms that interfere with daily functioning become noticeable. It may help patients cope more steadily with symptom fluctuations during periods of heightened discomfort. In clinical contexts, it is considered relevant in scenarios where additional management of discomfort is required, which is an application applied in settings marked by temporary physiological imbalance.

The core therapeutic domains include managing symptoms related to physical discomfort, symptoms associated with acute or episodic changes, and symptoms that become more disruptive during flare-ups. The product provides support that helps ease the overall symptom burden when symptom clusters appear suddenly or fluctuate. The medication helps address symptom clusters that may become intense or disruptive.

Quick Fact: Supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Eligibility: Who Can and Cannot Use Correctol?

The eligibility profile for Correctol (Bisacodyl) is strictly defined by regulatory documents, focusing on patient status, age, and existing medical conditions.

Contraindications and Exclusion

Use is prohibited for individuals with:

  • Hypersensitivity (allergy) to bisacodyl or any excipients.
  • Severe Dehydration.
  • Acute Abdominal Conditions such as intestinal obstruction, bowel perforation, acute inflammatory bowel diseases (e.g., appendicitis), toxic colitis, or toxic megacolon.

Age and Special Population Restrictions

Population Eligibility Status (Regulatory Basis)
Children Under 6 Generally Prohibited or Not Recommended by regulators.
Children 6 to <12 Use is Restricted to specific doses and often requires medical consultation.
Pregnancy/Lactation Use is limited to when clearly needed and generally requires professional guidance due to insufficient data.
Elderly Patients Use is allowed, but Caution is advised due to increased susceptibility to dehydration.

Comorbidity-Related Limitations

Eligibility is further limited by specific conditions. Patients with severe fluid/electrolyte loss or rare hereditary problems related to sugar intolerance (if relevant excipients are present) are advised against use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Bisacodyl, the active ingredient in Correctol, defines essential interaction constraints involving both co-administered medicines and certain food products.

Interactions Requiring Administration Timing Separation

The integrity of the enteric-coated tablet is protected by a mandatory regulatory restriction. Bisacodyl must not be taken within one hour of consuming Antacids, Proton Pump Inhibitors (PPIs), or Milk/Milk-Containing Products. This separation is required because these substances reduce upper gastrointestinal acidity, which could prematurely dissolve the coating, thus compromising drug delivery and potentially causing gastric irritation. This is a critical timing-based interaction rule.

Interactions Affecting Fluid and Electrolyte Balance

A documented pharmacodynamic interaction exists with medicines that can contribute to potassium loss. Co-administration with Diuretics or Adreno-corticosteroids (steroids) is officially noted as increasing the risk of hypokalaemia (low potassium) if Bisacodyl is used excessively. This resulting electrolyte imbalance is then officially linked to increased sensitivity to Cardiac Glycosides (such as Digoxin), a potentially clinically significant interaction. Furthermore, taking Bisacodyl with other Laxatives may result in enhanced gastrointestinal effects.

Mechanism of Action

How Correctol Works

The mechanism of action for Correctol, utilizing the active ingredient Bisacodyl, is defined by a dual, localized pharmacodynamic effect in the colon, impacting both muscular activity and fluid transport. Bisacodyl is a prodrug that requires local conversion by intestinal enzymes into the active metabolite, BHPM.

BHPM functions as a contact stimulant, acting directly on the enteric nervous system nerve endings in the colonic lining. This stimulation enhances reflex activity, increasing the frequency and force of High-Amplitude Propagated Contractions (HAPCs). This results in accelerated colonic transit through heightened motility.

Simultaneously, BHPM affects the colonic epithelial cells, initiating a secretagogue effect. It activates the cAMP signaling pathway, which promotes the active secretion of water and electrolytes (such as chloride ions) into the colonic lumen while inhibiting their reabsorption. The net increase in luminal water content alters the physical properties of the colonic material. The necessity of this site-specific enzymatic conversion dictates the mechanism-dependent delay in the initiation of colonic physiological changes.

Dosage and Administration Information

The administration of Correctol, which contains the active ingredient bisacodyl, involves specific oral dosage instructions. The medicine is provided as a 5 mg delayed-release tablet intended for the oral route of administration, and use should not exceed a specific time frame without consulting a health professional.

Official Dosing and Administration

Age Group Dose (5 mg tablets) Frequency
Adults and Children 12 years and over 1 to 3 tablets (5 mg to 15 mg) Single daily dose
Children 6 to under 12 years 1 tablet (5 mg) Single daily dose
Children under 6 years Ask a doctor N/A

Preparation and Timing Requirements

The tablet must be swallowed whole with a glass of water. The tablet should not be chewed, crushed, or split. Taking the medicine is often recommended at bedtime to produce a bowel movement within the typical 6-to-12-hour timeframe.

To ensure proper function, the tablet should not be taken within one hour after consuming milk, an antacid, or other dairy products. The duration of use for this non-prescription medicine is limited; do not use it for more than seven days unless directed by a doctor.

Recent Clinical Evidence

Research evidence / Overview of studies for Correctol (Bisacodyl)


Evidence Supporting Temporary Relief of Occasional Constipation

Research has explored the use of Bisacodyl in adults experiencing acute or temporary episodes of constipation. These investigations primarily involve short-term, randomized controlled trials (RCTs) where the compound was evaluated in study participants compared against an inactive substance (placebo). Researchers focused on outcomes describing episodic or acute changes, measuring the number of spontaneous bowel movements and changes in stool consistency.

Studies reported measurements of increased bowel movements in the studied groups compared to the placebo groups. The evidence supporting its use in contexts involving acute, temporary constipation comes from multiple, replicated trials. However, this research provides insight into short-term changes only. Long-term effects are not fully established because the trials were designed to assess a temporary situation.


Research for Use in Chronic Idiopathic Constipation

Bisacodyl was studied for its role in managing Chronic Idiopathic Constipation (CIC) in adults. These trials extended the observation period to intermediate-term durations, typically up to four weeks. The research specifically examined outcomes related to systemic or functional imbalance, primarily monitoring the weekly count of Complete Spontaneous Bowel Movements (CSBMs).

Studies reported measurements of a higher mean number of CSBMs per week in the study group compared to the placebo group over the observation period. A major limitation noted in the research is that follow-up durations were limited. Therefore, there is limited information for long-term outcomes regarding the sustained use of this type of laxative for chronic constipation, and comparative evidence is lacking in trials that run over many months.


Research Gaps and Areas of Uncertainty

Research gaps exist primarily in the lack of extensive, controlled data for long-term effects. The comparative evidence is lacking between Bisacodyl and other laxative classes over periods extending past a few weeks. Additionally, specific, dedicated, placebo-controlled research for Bisacodyl use in certain populations, such as children or those with specific comorbid conditions, is less abundant than in the general adult population. The research describes group findings and does not determine whether an individual will respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Correctol (FAQ)


Q: How quickly does Correctol typically start to work after taking it?

A: Official regulatory labeling indicates that the product generally produces a bowel movement between 6 and 12 hours after it has been taken orally. Regulatory directions for use often mention taking the dose at bedtime to coordinate the effect onset with a morning bowel movement.


Q: Is it normal to have stomach cramps after taking Correctol?

A: Product labeling confirms that stomach cramps, as well as stomach discomfort and faintness, are recognized as possible effects when using the product. If stomach discomfort becomes severe or if symptoms like abdominal pain, nausea, or vomiting occur before taking it, professional consultation is generally recommended.


Q: What is the difference between Correctol and a fiber supplement?

A: Correctol contains the active ingredient bisacodyl, which is formally classified as a stimulant laxative and works by directly influencing the colon’s nerve endings to increase muscle movement. In contrast, fiber supplements are generally classified as bulk-forming agents that work by increasing stool bulk and water content, rather than stimulating muscle activity.


Q: Will Correctol make me dependent on laxatives if I use it?

A: Prolonged or chronic use of any stimulant laxative is generally associated with the potential for developing laxative dependence. The official labeling includes an instruction to Stop use and ask a doctor if the product is needed for more than one week.


Q: Can taking Correctol cause dehydration or electrolyte imbalance?

A: The mechanism of this type of laxative includes promoting the secretion of fluid into the colon. Regulatory guidance notes that taking the product in excessive amounts may lead to fluid and electrolyte imbalance, such as low potassium (hypokalaemia), which is considered a serious effect.


Q: Is it safe to use Correctol while taking other non-prescription medicines?

A: Official labeling explicitly requires separation from other products by restricting use within one hour of taking an antacid or milk. In general, official guidance recommends professional discussion regarding the concurrent use of all over-the-counter (OTC) medicines.


Q: What should be done if no bowel movement occurs after using Correctol?

A: The labeling includes a requirement to Stop use and ask a doctor if the patient fails to have a bowel movement after using the product. This is because failure to have a movement after use may indicate a more serious underlying medical condition that requires professional evaluation.


Q: What should I watch out for that would be a serious side effect of Correctol?

A: Official warnings state that the user must stop use and seek professional attention if signs of a severe allergic reaction occur (such as hives, swelling, or difficulty breathing). Warnings also instruct the user to stop use and consult a doctor if they experience rectal bleeding or fail to have a bowel movement after taking the product.


Q: What are the signs of overuse or misuse of Correctol?

A: The regulatory warning indicates that using the product for more than one week or taking more than the directed amount is a potential indicator of misuse. Overuse may lead to serious health issues, including laxative dependence or disturbances in the body’s electrolyte balance.


Q: Does Correctol work primarily in the small or large intestine?

A: Correctol is formulated as an enteric-coated tablet specifically designed to deliver the active ingredient, bisacodyl, to the colon (large intestine). Its mechanism of action is described as locally stimulating the nerve endings in the colonic lining to promote movement.


Q: Are there specific food types that interact with Correctol?

A: The regulatory labeling explicitly restricts taking the tablet within one hour of consuming milk or products containing milk. This requirement is necessary to protect the enteric coating from dissolving prematurely, which could compromise the medicine's delivery and cause gastric irritation.


Q: What is the evidence that Correctol is effective for occasional constipation?

A: Studies of the active ingredient, bisacodyl, have reported measurements of increased bowel movements in studied groups compared to inactive substances (placebo). These findings are recognized as supporting its use for the short-term relief of occasional constipation.


Q: Does Correctol help with hard stools or mainly with frequency?

A: Research studies examining the effect of the active ingredient have measured outcomes related to both stool consistency and the frequency (number of bowel movements) experienced by participants. This suggests the product is recognized as having an effect on both factors.


Q: Can Correctol cause intestinal irritation?

A: The official product warnings highlight that gastric irritation can occur if the tablet is taken with milk or antacids, as these can cause the protective enteric coating to dissolve too early. Additionally, general stomach discomfort and cramping are noted as possible side effects during use.


Q: Does Correctol have any known interactions with herbal supplements?

A: Official regulatory documents contain general instructions that users should inform a health professional about all prescription and non-prescription medicines, vitamins, and supplements. This is the standard procedure for identifying and managing potential interactions.


Q: What happens if I miss a dose of Correctol?

A: This product is intended for the temporary relief of occasional constipation and is taken as a single daily dose when needed. The official labeling does not include instructions for a missed dose, implying it should only be taken as directed when symptoms occur.


Q: Is Correctol safe for women who are pregnant or breastfeeding?

A: The product labeling includes a requirement for women who are pregnant or breastfeeding to ask a health professional before use. This requirement is standard for many non-prescription medicines in these populations, as data may be limited.


Q: Does the body absorb the active ingredient in Correctol?

A: Regulatory summaries on the active ingredient indicate that its absorption from the gastrointestinal tract into the bloodstream is minimal. The tablet’s design (enteric coating) ensures the medicine acts primarily locally in the colon, limiting systemic effects.


Q: How is the active ingredient in Correctol eliminated from the body?

A: Since the active ingredient acts locally in the colon, the majority of the compound is mainly excreted in the feces. Any minor amount that is absorbed into the body is quickly metabolized and eliminated primarily through the urine.


Q: Can Correctol cause symptoms similar to appendicitis?

A: The labeling includes a specific warning and instruction to Ask a doctor before use if a patient has stomach pain, nausea, or vomiting. These symptoms are often associated with serious conditions that require professional evaluation.


Q: What are the typical ingredients besides the active one in Correctol tablets?

A: In addition to the active ingredient bisacodyl, the tablet formulation includes several inactive ingredients (excipients). These components, which include substances like lactose, various dyes, corn starch, and magnesium stearate, contribute to the pill's form and coating.


Q: Is there any difference in effect between taking Correctol in the morning versus at night?

A: The product generally produces an effect within 6 to 12 hours. While the effect is not stated to be different, taking the dose at bedtime is a common practice to coordinate the onset of the effect with a morning bowel movement, which may maximize convenience.

How should Correctol be stored and disposed of?

The storage and disposal instructions for Correctol (bisacodyl enteric-coated tablets) are strictly governed by regulatory labeling to maintain product quality and ensure safety.

Storage Conditions

Correctol must be stored at 25°C (77°F), with temperature fluctuations permitted between 15^circC and 30^circC (59^circF and 86^circF). The tablets must be protected from moisture and excessive humidity.

Store the medication in the container in which it was dispensed, kept tightly closed, and remain out of the reach of children.

Disposal Instructions

Discard the product when it is expired or no longer needed. The preferred disposal method is utilizing an authorized drug take-back program or mail-back service. If not available, unused tablets may be mixed with an unappealing substance, sealed in a bag, and disposed of in the household trash. Personal information must be scratched out from the packaging label before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Correctol found in:

A-Z Index: